Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials

By sjmartinez • October 30, 2023

Cheema HA, Shafiee A, Athar MMT, Rafiei MA, Mehmannavaz A, Jafarabady K, Shahid A, Ahmad A, Ijaz SH, Dani SS, Minhas AMK, Nashwan AJ, Fudim M, Fonarow GC. Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2023 Oct 12;10:1273781. doi: 10.3389/fcvm.2023.1273781. PMID: 37900570; PMCID: PMC10602781.

Tags: Cardiology/Epi, dapagliflozin, empagliflozin, heart failure, HFPEF, Publications, SGLT2I

Association of Ramus intermedius with increased atherosclerotic plaque in the left main stem

Pourafkari L, Ansari S, Kinninger A, Budoff MJ. Association of Ramus intermedius with increased atherosclerotic plaque in the left main stem. Int J Cardiovasc Imaging.[...]

Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial

DeVore AD, Majmudar M, Etters L, Xie J, Hao C, Lam PH, Hernandez AF, Fonarow GC, Desai AS. Digital Platform to Optimize Guideline-Directed Heart Failure[...]

Trinuclear Heptamethine Dyes for Shortwave Infrared In Vivo Imaging

Garcia CA, Lin EY, Mobley EB, Louie A, Hartung KM, Araujo JA, Sletten EM. Trinuclear Heptamethine Dyes for Shortwave Infrared In Vivo Imaging. Angew Chem[...]